J82.83
Eosinophilic asthma
Clinical Classification Guidelines
Code First
- asthma, by type, such as:
- mild intermittent asthma (J45.2-)
- mild persistent asthma (J45.3-)
- moderate persistent asthma (J45.4-)
- severe persistent asthma (J45.5-)
Medical Intelligence & Overview
Eosinophilic asthma is a subtype of asthma characterized by high levels of eosinophils, a type of white blood cell involved in allergic reactions and inflammation. This form of asthma often presents with more severe symptoms compared to other types and may require specialized approaches for management. Recognized under ICD-10 code J82.83, eosinophilic asthma primarily affects individuals with an allergic component, leading to recurrent episodes of airway narrowing, inflammation, and breathing difficulties.
Causes & Symptoms
Clinical Causes: Genetic predisposition to allergic reactions Environmental allergens such as pollen, mold, pet dander, and dust mites Exposure to air pollutants and irritants Previous respiratory infections that may trigger immune responses Certain medications or occupational exposures that induce allergic sensitivity
Key Symptoms: Persistent or episodic shortness of breath Wheezing sound during respiration Frequent coughing, especially at night or early morning Chest tightness or pressure Difficulty performing physical activities due to breathing problems Sputum production which may be thick and sticky
Diagnostic & Treatment
Diagnosis Path: Diagnosing eosinophilic asthma involves a combination of medical history, physical examinations, and specific tests. Key diagnostic procedures include: - Pulmonary Function Tests (PFTs) to evaluate airflow obstruction and reversibility - Blood tests to measure eosinophil levels, which are often elevated - Sputum analysis to identify eosinophil presence in mucus - Skin prick or allergy testing to identify specific triggers - Imaging studies such as chest X-rays to rule out other lung conditions Healthcare providers use these assessments to differentiate eosinophilic asthma from other asthma phenotypes or respiratory ailments, ensuring accurate diagnosis and tailored treatment plans.
Treatment Protocols: Managing eosinophilic asthma aims to control symptoms, prevent exacerbations, and improve quality of life. Treatment strategies typically involve: - Inhaled corticosteroids (ICS) to reduce airway inflammation and eosinophil activity - Leukotriene modifiers to decrease inflammatory responses - Biologic therapies, such as monoclonal antibodies targeting eosinophils (e.g., mepolizumab, reslizumab), particularly for severe cases - Short-acting beta-agonists (SABAs) for quick relief during acute episodes - Avoidance of known allergens and environmental triggers - Regular monitoring and follow-up consultations to adjust medications as needed In some cases, additional interventions like allergen immunotherapy may be recommended to reduce sensitivity. Collaborating with healthcare providers ensures that treatment plans are personalized to the individual's specific condition and needs.
Clinical Advice & FAQs
Billing Guidance
Is J82.83 a billable ICD-10 code?
Yes, J82.83 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J82.83?
Clinical documentation must specify the nature of Eosinophilic asthma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
